X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-30 | NRIX | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $19.85 | -3,690 | 55,937 | -6% | -$73,260 | |||||
| D | 2024-10-30 | NRIX | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $24.31 | -3,437 | 50,670 | -6% | -$83,536 | |||||
| D | 2024-07-30 | NRIX | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $20.67 | -3,408 | 45,150 | -7% | -$70,436 | |||||
| D | 2024-04-30 | NRIX | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $12.04 | -2,007 | 39,601 | -5% | -$24,169 | |||||
| D | 2024-01-30 | NRIX | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $7.99 | -2,334 | 36,402 | -6% | -$18,649 | |||||
| D | 2023-10-31 | NRIX | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $5.20 | -1,633 | 33,529 | -5% | -$8,487 | |||||
| D | 2023-07-31 | NRIX | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $9.65 | -1,884 | 29,955 | -6% | -$18,189 | |||||
| D | 2023-05-01 | NRIX | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $9.88 | -1,136 | 26,632 | -4% | -$11,219 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |